ClinicalTrials.govpublic full text
Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants
hiv infections, cabotegravir, long-acting injection, pharmacokinetics, safety, tolerability, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 859673
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.